Stress-related Alterations of Visceral Sensation: Animal Models for Irritable Bowel Syndrome Study

Overview

Journal J Neurogastroenterol Motil

Date 2011 Aug 24

PMID 21860814

Citations 36

Authors

Muriel Larauche

Agata Mulak

Yvette Tache

Affiliations

Soon will be listed here.

Abstract

Stressors of different psychological, physical or immune origin play a critical role in the pathophysiology of irritable bowel syndrome participating in symptoms onset, clinical presentation as well as treatment outcome. Experimental stress models applying a variety of acute and chronic exteroceptive or interoceptive stressors have been developed to target different periods throughout the lifespan of animals to assess the vulnerability, the trigger and perpetuating factors determining stress influence on visceral sensitivity and interactions within the brain-gut axis. Recent evidence points towards adequate construct and face validity of experimental models developed with respect to animals' age, sex, strain differences and specific methodological aspects such as non-invasive monitoring of visceromotor response to colorectal distension as being essential in successful identification and evaluation of novel therapeutic targets aimed at reducing stress-related alterations in visceral sensitivity. Underlying mechanisms of stress-induced modulation of visceral pain involve a combination of peripheral, spinal and supraspinal sensitization based on the nature of the stressors and dysregulation of descending pathways that modulate nociceptive transmission or stress-related analgesic response.

Citing Articles

The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies.

Krawczyk A, Sladowska G, Strzalka-Mrozik B Cancers (Basel). 2025; 17(5).

PMID: 40075568 PMC: 11899293. DOI: 10.3390/cancers17050719.

FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF agonist mediated visceral hypersensitivity in male rats.

Larauche M, Mulak A, Ha C, Million M, Arnett S, Germano P Neurogastroenterol Motil. 2024; 36(12):e14927.

PMID: 39344695 PMC: 11781189. DOI: 10.1111/nmo.14927.

Otilonium Bromide Prevents Cholinergic Changes in the Distal Colon Induced by Chronic Water Avoidance Stress, a Rat Model of Irritable Bowel Syndrome.

Traini C, Idrizaj E, Biagioni C, Baccari M, Vannucchi M Int J Mol Sci. 2023; 24(8).

PMID: 37108603 PMC: 10139220. DOI: 10.3390/ijms24087440.

Electrophysiology as a Tool to Decipher the Network Mechanism of Visceral Pain in Functional Gastrointestinal Disorders.

Alam M, Chen J Diagnostics (Basel). 2023; 13(4).

PMID: 36832115 PMC: 9955347. DOI: 10.3390/diagnostics13040627.

Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome.

Torres-Maravilla E, Holowacz S, Delannoy J, Lenoir L, Jacouton E, Gervason S Sci Rep. 2022; 12(1):19776.

PMID: 36396717 PMC: 9672316. DOI: 10.1038/s41598-022-21746-8.

References

Shen L, Kong H, Hou X . Prevalence of irritable bowel syndrome and its relationship with psychological stress status in Chinese university students. J Gastroenterol Hepatol. 2009; 24(12):1885-90. DOI: 10.1111/j.1440-1746.2009.05943.x. View

Wlodarska M, Willing B, Keeney K, Menendez A, Bergstrom K, Gill N . Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun. 2011; 79(4):1536-45. PMC: 3067531. DOI: 10.1128/IAI.01104-10. View

Fillingim R, King C, Ribeiro-Dasilva M, Rahim-Williams B, Riley 3rd J . Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009; 10(5):447-85. PMC: 2677686. DOI: 10.1016/j.jpain.2008.12.001. View

Zhuo M, Gebhart G . Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterology. 2002; 122(4):1007-19. DOI: 10.1053/gast.2002.32389. View

Peters K, Killinger K, A Ibrahim I . Childhood symptoms and events in women with interstitial cystitis/painful bladder syndrome. Urology. 2008; 73(2):258-62. DOI: 10.1016/j.urology.2008.09.014. View

Keita A, Soderholm J . The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil. 2010; 22(7):718-33. DOI: 10.1111/j.1365-2982.2010.01498.x. View

Sengupta J . Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol. 2009; (194):31-74. PMC: 3156094. DOI: 10.1007/978-3-540-79090-7_2. View

Mulak A, Bonaz B . Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit. 2004; 10(4):RA55-62. View

Tache Y, Million M, Nelson A, Lamy C, Wang L . Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med. 2005; 2(3):146-54. DOI: 10.1016/s1550-8579(05)80043-9. View

10.

Barreau F, Cartier C, Ferrier L, Fioramonti J, Bueno L . Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology. 2004; 127(2):524-34. DOI: 10.1053/j.gastro.2004.05.019. View

11.

Bakshi V, Kalin N . Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Biol Psychiatry. 2001; 48(12):1175-98. DOI: 10.1016/s0006-3223(00)01082-9. View

12.

Mendall M, Kumar D . Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol. 1998; 10(1):59-62. DOI: 10.1097/00042737-199801000-00011. View

13.

Martinez V, Wang L, Tache Y . Proximal colon distension induces Fos expression in the brain and inhibits gastric emptying through capsaicin-sensitive pathways in conscious rats. Brain Res. 2006; 1086(1):168-80. DOI: 10.1016/j.brainres.2006.02.063. View

14.

Berman S, Naliboff B, Suyenobu B, Labus J, Stains J, Ohning G . Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci. 2008; 28(2):349-59. PMC: 6670525. DOI: 10.1523/JNEUROSCI.2500-07.2008. View

15.

Drossman D, Leserman J, Nachman G, Li Z, Gluck H, Toomey T . Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990; 113(11):828-33. DOI: 10.7326/0003-4819-113-11-828. View

16.

Fukudo S . Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007; 42 Suppl 17:48-51. DOI: 10.1007/s00535-006-1942-7. View

17.

Piche M, Arsenault M, Poitras P, Rainville P, Bouin M . Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome. Pain. 2009; 148(1):49-58. DOI: 10.1016/j.pain.2009.10.005. View

18.

Trimble N, Johnson A, Foster A, Greenwood-Van Meerveld B . Corticotropin-releasing factor receptor 1-deficient mice show decreased anxiety and colonic sensitivity. Neurogastroenterol Motil. 2007; 19(9):754-60. DOI: 10.1111/j.1365-2982.2007.00951.x. View

19.

Murphy A, Suckow S, Johns M, Traub R . Sex differences in the activation of the spinoparabrachial circuit by visceral pain. Physiol Behav. 2009; 97(2):205-12. PMC: 2788429. DOI: 10.1016/j.physbeh.2009.02.037. View

20.

Bercik P . The microbiota-gut-brain axis: learning from intestinal bacteria?. Gut. 2011; 60(3):288-9. DOI: 10.1136/gut.2010.226779. View